Organization
University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom
2 abstracts
Abstract
ASSESSMENT OF THE COVID-19 PANDEMIC FROM THE PERSPECTIVE OF PEOPLE WITH RHEUMATIC MUSCULOSKELETAL DISEASES IN EUROPE. RESULTS FROM THE REUMAVID STUDY (PHASE 1)Org: Novartis Pharma AG, Hospital Universitario La Paz - CIBERONC, Universidad de Sevilla, Health & Territory Research (HTR), Sevilla, Spain, University of Leeds, Leeds Institute for Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom,
Abstract
ACPA POSITIVITY DETERMINES REMISSION IN PATIENTS WITH RA TREATED WITH IV AND SC ABATACEPT: A POST HOC ANALYSIS OF THE REAL-WORLD OBSERVATIONAL ACTION AND ASCORE STUDIESOrg: Schlosspark-Klinik, University Medicine Berlin, Department of Internal Medicine, Rheumatology, Berlin, Germany, Bristol Myers Squibb, Medical Immunology & Fibrosis, Munich, Germany, Bristol Myers Squibb, MESP France – Market Access, Rueil-Malmaison, France, ARC Amsterdam University Hospitals – VU University Medical & Reade, Department of Rheumatology, Amsterdam, Netherlands, Bristol Myers Squibb, Global Drug Development, Princeton, United States of America,